Author

Sima Ramezaninejad

Institution: Babol University of Medical Sciences

Observed institutions: Babol University of Medical Sciences, Mazandaran University of Medical Sciences

ORCID: 0000-0002-5955-4732

Observed ORCID: 0000-0002-5955-4732

OpenAlex ID: A5015849032

Evaluation of the Effect of N-acetylcysteine in the Prevention of Colistin Nephrotoxicity in Critically Ill Patients: A Randomized Controlled Trial

2024 · Amir Mohammad Shabani, Ahmad Alikhani, et al. · Journal of Research in Pharmacy Practice · 4

Diazoxide-Induced Hypertrichosis in a Neonate With Transient Hyperinsulinism

2023 · Seyyed Javad Boskabadi, Sima Ramezaninejad, et al. · Clinical Medicine Insights Case Reports · 4

Evaluation of the Safety and Efficacy of N-acetylcysteine in the Prevention of Paclitaxel-induced Peripheral Neuropathy: A Randomized, Double-blind, and Placebo-controlled Trial

2025 · Sima Ramezaninejad, Ehsan Zaboli, et al. · Journal of Research in Pharmacy Practice · 1

Severe Neurotoxicity due to Atropa belladonna Poisoning: A Case Report and Literature Review

2024 · Seyed Javad Boskabadi, Sima Ramezaninejad, et al. · Case Reports in Neurological Medicine · 1

Poor Sleep Quality and Its Associated Factors among Hospitalized Patients with Chronic Obstructive Pulmonary Disease: A Cross-Sectional Study

2026 · Hosein Ghanbarnia, Reza Mohseni Ahangar, et al. · Research Square

Extensive Subcutaneous Hematoma in a Patient Receiving Nigella sativa Oil, Dual Antiplatelet Therapy, and Oxaliplatin-Based Chemotherapy: A Case Report

2026 · Amirhosein Arab, Sima Ramezaninejad, et al. · Hospital Pharmacy

Albumin Utilization Evaluation in a Teaching University Hospital in Iran

2026 · Ebrahim Salehifar, Zahra Bagherzadegan, et al. · DOAJ (DOAJ: Directory of Open Access Journals)

Fiberoptic Reintubation in an Unanticipated Difficult Airway: A Case Report

2026 · Alireza Nikzad-Jamnani, Seyyed Alireza Seyyed Siamdoust, et al. · Case Reports in Anesthesiology

The Efficacy and Safety of Adding Chlorpromazine to Atazanavir/Ritonavir Regimen in the Treatment of Moderate COVID-19 Patients, a Randomized Double-blind Clinical Trial

2023 · Sima Ramezaninejad, Hamid Reza Namvar, et al. · Pharmaceutical and Biomedical Research

Works count: 10

Citation count: 11

H-index: 2

I10-index: